ReviewDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes.

Taichi Nagahisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.